Bio Preventive Medicine Corp., a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It also provides DNlite test, a series of patented and clinically validated non-invasive urine test for monitoring the progression of diabetic nephropathy, including DNlite-IVD103 and DNlite-DN_Score. Bio Preventive Medicine Corp. was founded in 2014 and is headquartered in Zhubei, Taiwan.
Frequently asked questions
What sector does Bio Preventive Medicine Corp. (6810) operate in?
Bio Preventive Medicine Corp. belongs to the Other sector and operates in the Biotechnology industry.
What is Bio Preventive Medicine Corp. (6810) current stock price?
As of the latest data, Bio Preventive Medicine Corp. stock price is NT$22.95, with a previous close of NT$23.95. Bio Preventive Medicine Corp. lost -NT$1.00 in the last trading session, representing a -4.18% loss.
What is Bio Preventive Medicine Corp. (6810) current market capitalization?
Bio Preventive Medicine Corp. market cap is approximately 1.13 billion.
What is Bio Preventive Medicine Corp. (6810) Earnings Per Share (EPS)?
The trailing EPS is -NT$2.02.
Does Bio Preventive Medicine Corp. (6810) pay dividends?
No. Bio Preventive Medicine Corp. does not pay a dividend.
What is Bio Preventive Medicine Corp. (6810) beta (volatility) score?
Bio Preventive Medicine Corp. has a beta of 0.505, indicating lower volatility than the overall market.